Rhumbline Advisers Acquires 9,514 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL)
Rhumbline Advisers boosted its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 4.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 223,115 shares of the biopharmaceutical company’s stock after purchasing an additional 9,514 shares during the quarter. Rhumbline Advisers’ holdings in Ocular Therapeutix were worth $1,635,000 as of its most recent […]
Rhumbline Advisers boosted its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 4.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 223,115 shares of the biopharmaceutical company’s stock after purchasing an additional 9,514 shares during the quarter. Rhumbline Advisers’ holdings in Ocular Therapeutix were worth $1,635,000 as of its most recent […]
